Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5177951
Max Phase: Preclinical
Molecular Formula: C14H9N3O4
Molecular Weight: 283.24
Associated Items:
ID: ALA5177951
Max Phase: Preclinical
Molecular Formula: C14H9N3O4
Molecular Weight: 283.24
Associated Items:
Canonical SMILES: O=C(Nc1cccc([N+](=O)[O-])c1)c1noc2ccccc12
Standard InChI: InChI=1S/C14H9N3O4/c18-14(13-11-6-1-2-7-12(11)21-16-13)15-9-4-3-5-10(8-9)17(19)20/h1-8H,(H,15,18)
Standard InChI Key: QBOMNJBGPXUABG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 283.24 | Molecular Weight (Monoisotopic): 283.0593 | AlogP: 2.99 | #Rotatable Bonds: 3 |
Polar Surface Area: 98.27 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.04 | CX Basic pKa: | CX LogP: 2.77 | CX LogD: 2.77 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.59 | Np Likeness Score: -1.97 |
1. Xue Z, Li H, Xie W, Xu Y, Zhou L, Qu ZB.. (2022) Benzo[d]isoxazole Derivatives as Hypoxia-Inducible Factor (HIF)-1α Inhibitors., 13 (12.0): [PMID:36518694] [10.1021/acsmedchemlett.2c00308] |
Source(1):